While Novo Nordisk and Lilly are the undisputed leaders in weight management right now, a number of pharmaceutical companies ...

Stay informed with Hindustan Times' live updates! Track the latest lifestyle news including fashion trends, style guide & ...

Today’s health headlines are all about the eyes. Dr. Vicente Diaz, an eye doctor at Yale Medicine and professor of ...

Carter also said that the longer diabetics wait to get their eyes checked, the more at risk they are for potential eye-sight ...

HERSHEY, PA. — GLP-1 weight-loss drugs are having a “mild impact” on The Hershey Co.’s business, president and chief ...

HERSHEY, PA. — GLP-1 weight-loss drugs are having a “mild impact” on The Hershey Co.’s business, president and chief executive officer Michele Buck told analysts in a conference call on fiscal 2024 ...

I had never seen this bird's-eye angle: It was clear my temples were receding ... There’s been talk of GLP-1 and semaglutide ...

A recent poll found that about 15.5 million Americans have used injectable diabetes medicines like Ozempic and Wegovy to lose ...

Sharon Osbourne reignited surgery speculations as she was pictured out and about in Los Angeles.Three years after getting her ...

It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...